Pioglitazone in Hepatitis C

NCT00189163 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Pioglitazone
DRUG: Placebo Oral Tablet

Sponsor

University of Michigan